Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2,133 INR | +3.26% | +14.12% | +12.40% |
25/04 | GlaxoSmithKline sues Pfizer and BioNTech over Covid-19 vaccine technology | RE |
22/03 | GlaxoSmithKline Pharmaceuticals Limited Receives Orders from Government Authorities | CI |
Sales 2024 * | 33.65B 404M | Sales 2025 * | 36.49B 438M | Capitalization | 361B 4.33B |
---|---|---|---|---|---|
Net income 2024 * | 6.06B 72.72M | Net income 2025 * | 7.68B 92.09M | EV / Sales 2024 * | 10.7 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 9.9 x |
P/E ratio 2024 * |
53.1
x | P/E ratio 2025 * |
47.1
x | Employees | 3,680 |
Yield 2024 * |
1.42% | Yield 2025 * |
1.48% | Free-Float | 24.42% |
1 day | +3.26% | ||
1 week | +14.12% | ||
Current month | +9.76% | ||
1 month | +10.82% | ||
3 months | -2.23% | ||
6 months | +47.99% | ||
Current year | +12.40% |
Managers | Title | Age | Since |
---|---|---|---|
Bhushan Akshikar
CEO | Chief Executive Officer | 54 | 01/22/01 |
Juby Chandy
DFI | Director of Finance/CFO | - | 01/22/01 |
Simrat Sohal
CMP | Compliance Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Renu Sud Karnad
CHM | Chairman | 70 | 01/19/01 |
Manu Anand
BRD | Director/Board Member | 64 | 16/22/16 |
Director/Board Member | 74 | 30/15/30 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.01% | 4 M€ | -4.41% | - | |
0.01% | 117 M€ | +1.11% | - | |
0.00% | 31 M€ | +3.50% | - |
Date | Price | Change | Volume |
---|---|---|---|
26/24/26 | 2,133 | +3.26% | 6,612 |
25/24/25 | 2,065 | -0.69% | 14,837 |
24/24/24 | 2,080 | +7.06% | 20,430 |
23/24/23 | 1,943 | -0.28% | 3,115 |
22/24/22 | 1,948 | +4.24% | 5,393 |
Delayed Quote Bombay S.E., April 26, 2024 at 03:49 pm IST
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+12.40% | 4.33B | |
+25.83% | 661B | |
+27.00% | 566B | |
-6.76% | 352B | |
+20.34% | 332B | |
+3.00% | 283B | |
+13.09% | 231B | |
+5.46% | 200B | |
-9.61% | 195B | |
-6.26% | 145B |
- Stock Market
- Equities
- GLAXO Stock